Incidence and risk factors in sudden unexpected death in epilepsy

Thaddeus S. Walczak, I. E. Leppik, M. D'Amelio, J. Rarick, E. So, P. Ahman, K. Ruggles, Gregory D Cascino, J. F. Annegers, W. A. Hauser

Research output: Contribution to journalArticle

354 Citations (Scopus)

Abstract

Objective: To determine incidence of and risk factors for sudden unexpected death in epilepsy (SUDEP). Methods: Three epilepsy centers enrolled 4,578 patients and prospectively followed these patients for 16,463 patient-years. The cohort was screened for death annually. Deaths were investigated to determine whether SUDEP occurred. Potential risk factors were compared in SUDEP cases and in controls enrolled contemporaneously at the same center. Results: Incidence of SUDEP was 1.21/1,000 patient-years and was higher among women (1.45/1,000) than men (0.98/1,000). SUDEP accounted for 18% of all deaths. Occurrence of tonic-clonic seizures, treatment with more than two anticonvulsant medications, and full-scale IQ less than 70 were independent risk factors for SUDEP. The number of tonic-clonic seizures was a risk factor only in women. The presence of cerebral structural lesions and use of psychotropic drugs at the last visit were not risk factors for SUDEP in this cohort. Subtherapeutic anticonvulsant levels at the last visit were equally common in the two groups. No particular anticonvulsant appeared to be associated with SUDEP. Conclusions: These results support the idea that tonic-clonic seizures are an important proximate cause of SUDEP. This information creates a risk profile for SUDEP that may help direct preventative efforts.

Original languageEnglish (US)
Pages (from-to)519-525
Number of pages7
JournalNeurology
Volume56
Issue number4
StatePublished - Feb 27 2001

Fingerprint

Sudden Death
Epilepsy
Incidence
Anticonvulsants
Seizures
Psychotropic Drugs

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Walczak, T. S., Leppik, I. E., D'Amelio, M., Rarick, J., So, E., Ahman, P., ... Hauser, W. A. (2001). Incidence and risk factors in sudden unexpected death in epilepsy. Neurology, 56(4), 519-525.

Incidence and risk factors in sudden unexpected death in epilepsy. / Walczak, Thaddeus S.; Leppik, I. E.; D'Amelio, M.; Rarick, J.; So, E.; Ahman, P.; Ruggles, K.; Cascino, Gregory D; Annegers, J. F.; Hauser, W. A.

In: Neurology, Vol. 56, No. 4, 27.02.2001, p. 519-525.

Research output: Contribution to journalArticle

Walczak, TS, Leppik, IE, D'Amelio, M, Rarick, J, So, E, Ahman, P, Ruggles, K, Cascino, GD, Annegers, JF & Hauser, WA 2001, 'Incidence and risk factors in sudden unexpected death in epilepsy', Neurology, vol. 56, no. 4, pp. 519-525.
Walczak TS, Leppik IE, D'Amelio M, Rarick J, So E, Ahman P et al. Incidence and risk factors in sudden unexpected death in epilepsy. Neurology. 2001 Feb 27;56(4):519-525.
Walczak, Thaddeus S. ; Leppik, I. E. ; D'Amelio, M. ; Rarick, J. ; So, E. ; Ahman, P. ; Ruggles, K. ; Cascino, Gregory D ; Annegers, J. F. ; Hauser, W. A. / Incidence and risk factors in sudden unexpected death in epilepsy. In: Neurology. 2001 ; Vol. 56, No. 4. pp. 519-525.
@article{1b37fda53bf240169bc579790c88c27b,
title = "Incidence and risk factors in sudden unexpected death in epilepsy",
abstract = "Objective: To determine incidence of and risk factors for sudden unexpected death in epilepsy (SUDEP). Methods: Three epilepsy centers enrolled 4,578 patients and prospectively followed these patients for 16,463 patient-years. The cohort was screened for death annually. Deaths were investigated to determine whether SUDEP occurred. Potential risk factors were compared in SUDEP cases and in controls enrolled contemporaneously at the same center. Results: Incidence of SUDEP was 1.21/1,000 patient-years and was higher among women (1.45/1,000) than men (0.98/1,000). SUDEP accounted for 18{\%} of all deaths. Occurrence of tonic-clonic seizures, treatment with more than two anticonvulsant medications, and full-scale IQ less than 70 were independent risk factors for SUDEP. The number of tonic-clonic seizures was a risk factor only in women. The presence of cerebral structural lesions and use of psychotropic drugs at the last visit were not risk factors for SUDEP in this cohort. Subtherapeutic anticonvulsant levels at the last visit were equally common in the two groups. No particular anticonvulsant appeared to be associated with SUDEP. Conclusions: These results support the idea that tonic-clonic seizures are an important proximate cause of SUDEP. This information creates a risk profile for SUDEP that may help direct preventative efforts.",
author = "Walczak, {Thaddeus S.} and Leppik, {I. E.} and M. D'Amelio and J. Rarick and E. So and P. Ahman and K. Ruggles and Cascino, {Gregory D} and Annegers, {J. F.} and Hauser, {W. A.}",
year = "2001",
month = "2",
day = "27",
language = "English (US)",
volume = "56",
pages = "519--525",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Incidence and risk factors in sudden unexpected death in epilepsy

AU - Walczak, Thaddeus S.

AU - Leppik, I. E.

AU - D'Amelio, M.

AU - Rarick, J.

AU - So, E.

AU - Ahman, P.

AU - Ruggles, K.

AU - Cascino, Gregory D

AU - Annegers, J. F.

AU - Hauser, W. A.

PY - 2001/2/27

Y1 - 2001/2/27

N2 - Objective: To determine incidence of and risk factors for sudden unexpected death in epilepsy (SUDEP). Methods: Three epilepsy centers enrolled 4,578 patients and prospectively followed these patients for 16,463 patient-years. The cohort was screened for death annually. Deaths were investigated to determine whether SUDEP occurred. Potential risk factors were compared in SUDEP cases and in controls enrolled contemporaneously at the same center. Results: Incidence of SUDEP was 1.21/1,000 patient-years and was higher among women (1.45/1,000) than men (0.98/1,000). SUDEP accounted for 18% of all deaths. Occurrence of tonic-clonic seizures, treatment with more than two anticonvulsant medications, and full-scale IQ less than 70 were independent risk factors for SUDEP. The number of tonic-clonic seizures was a risk factor only in women. The presence of cerebral structural lesions and use of psychotropic drugs at the last visit were not risk factors for SUDEP in this cohort. Subtherapeutic anticonvulsant levels at the last visit were equally common in the two groups. No particular anticonvulsant appeared to be associated with SUDEP. Conclusions: These results support the idea that tonic-clonic seizures are an important proximate cause of SUDEP. This information creates a risk profile for SUDEP that may help direct preventative efforts.

AB - Objective: To determine incidence of and risk factors for sudden unexpected death in epilepsy (SUDEP). Methods: Three epilepsy centers enrolled 4,578 patients and prospectively followed these patients for 16,463 patient-years. The cohort was screened for death annually. Deaths were investigated to determine whether SUDEP occurred. Potential risk factors were compared in SUDEP cases and in controls enrolled contemporaneously at the same center. Results: Incidence of SUDEP was 1.21/1,000 patient-years and was higher among women (1.45/1,000) than men (0.98/1,000). SUDEP accounted for 18% of all deaths. Occurrence of tonic-clonic seizures, treatment with more than two anticonvulsant medications, and full-scale IQ less than 70 were independent risk factors for SUDEP. The number of tonic-clonic seizures was a risk factor only in women. The presence of cerebral structural lesions and use of psychotropic drugs at the last visit were not risk factors for SUDEP in this cohort. Subtherapeutic anticonvulsant levels at the last visit were equally common in the two groups. No particular anticonvulsant appeared to be associated with SUDEP. Conclusions: These results support the idea that tonic-clonic seizures are an important proximate cause of SUDEP. This information creates a risk profile for SUDEP that may help direct preventative efforts.

UR - http://www.scopus.com/inward/record.url?scp=0035957118&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035957118&partnerID=8YFLogxK

M3 - Article

C2 - 11222798

AN - SCOPUS:0035957118

VL - 56

SP - 519

EP - 525

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 4

ER -